SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient…
<!-- Name:DistributionId Value:8832286 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Browsing Tag
SPR Therapeutics
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an…
<!-- Name:DistributionId Value:8742711 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
CLEVELAND, Nov. 17, 2022 (GLOBE NEWSWIRE) -- At the 21st Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in Orlando, SPR Therapeutics is highlighting five new…
SPR Therapeutics Announces 10,000th SPRINT PNS Procedure for Patients Suffering from…
CLEVELAND, May 12, 2022 (GLOBE NEWSWIRE) -- Cleveland based medical device company SPR Therapeutics today announced a key milestone with the 10,000th patient treated using the SPRINT® PNS…
Prolonged Temporary Neurostimulation Treatment Period Offered by the SPRINT® PNS…
CLEVELAND, March 15, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced publication of a study in the Journal of Pain Research demonstrating how a longer initial treatment period may…
The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain…
CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics has been honored with three President’s Choice Abstract Awards at the 20th Annual ASRA Pain Medicine Meeting taking place…
SPR Therapeutics CEO Maria Bennett Selected as Winner of EY Entrepreneur of the Year…
CLEVELAND, Aug. 06, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics is proud to announce that President, Founder and CEO Maria Bennett has been selected as an Ernst & Young (EY)…